Nifedapine for Protracted Withdrawal Syndrome

De Soto C.B. , O'Donnell W.E.I. , Allred L.J. Symptomotology in alcoholics at various stages of abstinence. Alcoholism: Clin Ext Res 1985; 9: 505–512.

Segal B.M. , Kushnarev V.M. , Urakov I.G. Alcoholism and disruption of activity of deep cerebral structures. Q J Stud Alcohol 1970; 31: 587–601.

Littleton J. Alcohol intoxication and physical dependence: a molecular mystery tour. Br J Addict 19R9; 84: 267–276.

Little H.J. , Dolin S.J. , llalsey M.J. Calcium channel antagonists decrease the ehanol withdrawal syndrome. Life Sci 1986; 39: 2059–2065.

Katta B.B. , Isaac M.K. The role of calcium entry blocker nifedapine in alcohol withdrawal syndrome. Implications for treatment of alcohol dependence. Paper presented at Indo-US Symposium on molecular mechanisms underlying neural response to damage. February 6–10, Nimhans, Bangalore.

Marlatt G.A. , George W.H. Relapse prevention. Introduction and Overview of the model. Br J Addict 1984; 79: 261–273.